SMS Lifesciences India Limited has announced key dates and initiatives for its shareholders, including a record date for dividend eligibility and a new campaign to address unclaimed dividends.

Record Date and Annual General Meeting

The company has fixed September 24, 2025, as the record date for two important purposes:

1. Determining shareholder eligibility for dividend payments for the financial year 2024-25
2. Establishing voting rights for the 19th Annual General Meeting (AGM)

The AGM is scheduled for September 30, 2025, at 3:00 pm. Shareholders on record as of September 24, 2025, will be entitled to participate in the voting process during the AGM.

Dividend Payment Details

If approved by shareholders at the AGM, the dividend will be paid within 30 days, subject to tax deduction at source. The company plans to credit the dividend directly to shareholders' bank accounts.

'Saksham Niveshak' Campaign Launch

SMS Lifesciences has launched the 'Saksham Niveshak' campaign to address unclaimed dividends and improve shareholder engagement. This 100-day initiative will run from July 28 to November 6, 2025, with the following objectives:

1. Reduce the quantum of unclaimed dividends
2. Facilitate KYC (Know Your Customer) updates for shareholders
3. Encourage bank mandate registrations
4. Assist shareholders in claiming unpaid dividends from 2018-19 to 2023-24

The campaign aims to prevent the transfer of shares and dividends to the Investor Education and Protection Fund Authority (IEPFA) by encouraging shareholders to update their records and claim entitlements directly from the company.

Shareholder Action Required

Eligible shareholders who have not yet claimed their dividends or updated their KYC details are urged to take action. They can contact the company's Registrar and Transfer Agent (RTA):

Aarthi Consultants Private Limited 1-2-285, Domalguda Hyderabad – 500029 Phone: 040 2763811 Email: info@aarthiconsultants.com

Compliance and Transparency

This initiative aligns with the Ministry of Corporate Affairs' circular dated July 16, 2025, and the Investor Education and Protection Fund Authority's efforts to empower investors. It demonstrates SMS Lifesciences' commitment to transparency, investor facilitation, and compliance with the Companies Act, 2013, and SEBI guidelines.

By taking these steps, SMS Lifesciences aims to enhance shareholder engagement and ensure that rightful claimants can easily update their records and claim their entitlements, thereby reducing the risk of share and dividend transfers to the IEPF.

SMS Lifesciences India Limited , a manufacturer of Active Pharmaceutical Ingredients (APIs) and their intermediates, has released its financial results for the first quarter, showing a decline in revenue and profit compared to the same period last year.

Financial Performance

The company reported the following standalone financial results for Q1:

SMS Lifesciences India experienced a decrease in revenue from operations, which stood at Rs. 7,904.27 lakhs for the quarter, compared to Rs. 8,657.06 lakhs in the corresponding quarter of the previous year, marking a decline of 8.70%.

The company's net profit decreased to Rs. 515.77 lakhs from Rs. 645.99 lakhs in the previous year's quarter, representing a 20.16% year-over-year reduction. Consequently, the earnings per share (EPS) also declined to Rs. 17.06 from Rs. 21.37 in the same period last year.

Consolidated Results

On a consolidated basis, which includes the results of its subsidiary Mahi Drugs Private Limited, SMS Lifesciences India reported:

• Revenue from operations of Rs. 8,250.46 lakhs, down from Rs. 9,254.82 lakhs in the previous year's quarter
• Net profit of Rs. 438.21 lakhs, compared to Rs. 709.63 lakhs in the previous year's quarter

Board Meeting Outcomes

The company's Board of Directors met on August 11 and approved several key items:

1. The unaudited standalone and consolidated financial results for Q1
2. The Board Report for the year ended March 31
3. Scheduling of the 19th Annual General Meeting (AGM) for September 30, to be conducted through video conferencing
4. Approval of various policies, including:
   • Code of Conduct for Prevention of Insider Trading
   • Policy on determination of material events information
   • Policy for Prevention of Sexual Harassment

Annual General Meeting

SMS Lifesciences India Limited has scheduled its 19th Annual General Meeting for Tuesday, September 30. The meeting will be held through video conferencing mode, in compliance with the latest SEBI and MCA circulars.

Auditor's Review

Rambabu & Co., Chartered Accountants, conducted a limited review of the financial results and expressed an unmodified opinion on both the standalone and consolidated financial statements for the quarter.

The company continues to focus on its core business of manufacturing Active Pharmaceutical Ingredients and their intermediates, which constitutes a single reportable business segment as per Indian Accounting Standard 108.

Investors and stakeholders can access the detailed financial results and newly approved policies on the company's website at www.smslife.in/policies.php .